Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : NA
May 18,2024
Price(EOD): ₹ 51.94
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 145.95 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on May 20,2019 (price: ₹ 21.20)

₹ 1 L

₹ 2.45 L

1W : -0.1% 1M : 10.5% 1Y : 78.8%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -0.1% 10.5% 78.8%
SUN PHARMACEUTICAL INDUSTRIES -0.9% 0.9% 62.6%
CIPLA 3.5% 4.2% 51.8%
DR REDDYS LABORATORIES -1% -2.4% 28.4%
ZYDUS LIFESCIENCES 12.2% 18% 103.8%
DIVIS LABORATORIES 0.8% 5.6% 19.3%
MANKIND PHARMA -6.1% -11.9% 54.1%
TORRENT PHARMACEUTICALS 2.9% 6.2% 66.2%
LUPIN 1.5% 4.2% 109.2%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : May 18,2024 ]

Ratio Standalone
P/E
P/B
P/S
38.56
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 3.78 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

1.27
P/B Calculated based on Book Value of Rs 115.09 Cr
[Latest Year - Mar2023 - Standalone Results ]

0.42
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 12% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
933%
282%
192%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS



AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
0.33
0.13
0.19
0.22
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
32.24%
46.29%
45.53%
143.24%
22.42%
76.72%
96.25%
91.27%
QtrlyTrend
8
Latest Qtr: Dec2023
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on May 18,2024, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on May 18,2024, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on May 18,2024, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 13.58 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 5.03
Fair Value [Median EV / Sales Model] : Rs. 13.58
Fair Value [Median Price / Sales Model] : Rs. 17.78
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 13.58

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on May 18,2024, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 282% based on the estimates of Median Intrinsic Value!